Skip to main content
Caplight Logo









Lumeda Inc.

Lumeda Inc.

Private
ConnecticutHealthcare & Life Scienceshttps://oncoluxinc.com

Last Round

Series A

Apr 8, 2021

Total Funding Raised

$5.3M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Lumeda Inc. is a medical technology company that develops a photodynamic therapy (PDT) platform, DigiLum™, as an adjuvant treatment for patients with non-small cell lung cancer (NSCLC) and other thoracic malignancies.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Biotechnology, Clinical Trials, Medical AI

Business Model

B2B

Customer Profile

Hardware Sales, Usage-Based SaaS, Government Contracts

AI Layer

Non-AI

Keywords

photodynamic therapyPDTlight dosimetryintraoperative therapymedical devicecancer therapyautomated light deliverysoftware-controlled dosimetryadjuvant therapylung cancer therapyNSCLCthoracic surgery toolsmedtechcapital equipment salessingle-use applicatorspleural malignanciescolorectal cancermachine-learning algorithms

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Lumeda Inc. Comparables

Compare Lumeda Inc. with similar companies based on industry and business-model similarity.

Lumeda Inc. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Hemerion Therapeutics
78%
Modulight Oyj
74%
Illumacell Inc.
71%

Lumeda Inc. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AApr 8, 2021
SeedJun 4, 2020

Lumeda Inc. Investors

Notable investors and investment history

Lumeda Inc. investors
InvestorRounds
Connecticut InnovationsSeed, Series A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 27, 2026

    Open roles increased to 8, 800% of headcount.

Lumeda Inc. Filings

Explore SEC and related filing metadata, where available.

Lumeda Inc. filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Lumeda Inc.'s valuation, stock price, and market status.

Is Lumeda Inc. a public or private company?

Lumeda Inc. is a private company.

What is the current stock price of Lumeda Inc.?

Lumeda Inc. is a private company, so its shares have no public market price. Caplight tracks Lumeda Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Lumeda Inc. worth (valuation)?

Valuation information for Lumeda Inc. is not publicly available.

Can I buy Lumeda Inc. stock?

Lumeda Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Lumeda Inc.'s last funding round?

Lumeda Inc.'s most recent funding round was Series A on April 8, 2021.

Who are the main investors in Lumeda Inc.?

Key investors in Lumeda Inc. include Connecticut Innovations.

Will Lumeda Inc. IPO soon?

No public IPO plans have been announced for Lumeda Inc..

How can I track Lumeda Inc. secondary market activity?

Caplight tracks bids, offers, and trades in Lumeda Inc.'s shares on secondary markets.

Firmographic Details

HeadquartersConnecticut
Employee Range1
Year Founded2020
Last FundingApr 8, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?